• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 58 of 100
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
Health
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
Health
The Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Elijah Cummings, Peter Welch
Health
House Democrats Start Multiple Sclerosis Drug Price Probe
By BloombergAugust 17, 2017
Fosun International Ltd. Chairman And Billionaire Guo Guangchang Attends Interim Results News Conference
Finance
China’s Fosun Is Defying Beijing’s Crackdown on Debt and Foreign M&A
By Fortune Editors and ReutersAugust 14, 2017
Forbes Under 30 Summit
Health
Why SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
Why Martin Shkreli Won’t Be the Last Pharma Bro
Commentary
Why Martin Shkreli Won’t Be the Last Pharma Bro
By Josh HoxieAugust 8, 2017
Hepatitis C drug can cure, if patients can get it
Health
The FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
Inside Teva Pharmaceuticals Headquarters
Finance
Pharma Giant Teva’s Stock Is Imploding As Generic Drugs Get Cheaper
By BloombergAugust 3, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Finance
Jury in Martin Shkreli Trial Asks the Judge to Define ‘Fraudulent Intent’
By ReutersAugust 1, 2017
World Science Festival
Health
What You Should Know About ALS, The Disease That Killed Actor and Playwright Sam Shepard
By Sy MukherjeeJuly 31, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
Finance
Jury to Soon Begin Deliberations in ‘Pharma Bro’ Martin Shkreli’s Fraud Trial
By ReutersJuly 28, 2017
A sign is seen at an AstraZeneca site in Macclesfield
Health
Here’s Why Shares in This Former Pfizer Target Are Tanking
By Fortune Editors and ReutersJuly 27, 2017
Close up of blister packs red pills
Mitsubishi Tanabe Pharma Is Buying Neuroderm in a $1.1 Billion Bid to Expand Its U.S. Business
By ReutersJuly 24, 2017
Cystic fibrosis drug campaign
Health
This Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail
By Sy MukherjeeJuly 19, 2017
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
Health
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
1...
  • 56
  • 57
  • 58
  • 59
  • 60
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’placeholder alt text
By Preston ForeSeptember 20, 2026
Economy
Elon Musk’s DOGE swiped $329 million in humanitarian funding from Nepal, leaving a Gen Z tech revolution to transform the budding country’s economyplaceholder alt text
By Sasha RogelbergSeptember 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.